Apex Pharma Marketing Pte Ltd, headquartered in Singapore (SG), is a prominent player in the pharmaceutical marketing industry, specialising in the distribution and promotion of innovative healthcare products. Founded in 2005, the company has established a strong presence across Southeast Asia, focusing on enhancing patient access to essential medications and healthcare solutions. With a diverse portfolio that includes prescription medications, over-the-counter products, and health supplements, Apex Pharma distinguishes itself through its commitment to quality and customer-centric services. The company has achieved significant milestones, including strategic partnerships with leading pharmaceutical manufacturers, which have bolstered its market position. Apex Pharma continues to be recognised for its dedication to improving health outcomes, making it a trusted name in the pharmaceutical sector.
How does Apex Pharma Marketing Pte Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Apex Pharma Marketing Pte Ltd.'s score of 42 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Apex Pharma Marketing Pte Ltd., headquartered in Singapore (SG), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Apex Healthcare Berhad, which may influence its climate commitments and reporting practices. While Apex Pharma Marketing Pte Ltd. has not established its own reduction targets or climate pledges, it is important to note that it inherits data and initiatives from its parent company, Apex Healthcare Berhad. This relationship may provide a framework for future climate action and emissions reporting. As of now, there are no specific reduction initiatives or targets outlined for Apex Pharma Marketing Pte Ltd. However, the company is positioned within an industry increasingly focused on sustainability and carbon footprint reduction. This context suggests a potential for future commitments aligned with broader corporate sustainability goals.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 90,900 | 00,000 |
| Scope 2 | 9,761,100 | 00,000,000 |
| Scope 3 | 1,801,600 | 0,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Apex Pharma Marketing Pte Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.